Home » Topics » Regulatory

Regulatory
RSS

Procrit cleared for new indication

Jan. 3, 1997

New HRT patch approved for launch in U.S.

Jan. 3, 1997

Generic antidiabetic agent approved by FDA

Jan. 3, 1997

Andrx freed to market Dilacor XR bioequivalent

Jan. 3, 1997

Watson's first NDA product approved

Jan. 3, 1997

Two FDA approvals for Taro

Jan. 3, 1997

Lipid effects of two gestodene/ethinylestradiol combinations compared

Jan. 3, 1997

Ciprofloxacin ophthalmic solution effective in treating bacterial corneal ulcers

Jan. 3, 1997

Expanded use of acellular DTP vaccine approved

Dec. 31, 1996

Nutropin cleared for marketing

Dec. 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...